Hepatobiliary Pancreat Dis Int  2023, Vol. 22 Issue (4): 437-438 DOI: 10.1016/j.hbpd.2023.02.004 |
|
|||
| Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications | |||
| Stergios A Polyzos a , ∗, Jannis Kountouras b , Athanasios D Anastasilakis c , Evangelos Terpos d | |||
| a First Laboratory of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece b Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece c Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Macedonia, Greece d Department of Clinical Therapeutics, School of Medicine, National and Kapodestrian University of Athens, Athens, Greece ∗ Corresponding author. E-mail address: spolyzos@auth.gr (S.A. Polyzos). |
|||
|
|||||||||||||||||||||||||||||||||||||||||||
